Extract notice to the Minister

NRA-Dapagliflozin

Common name / Subject : dapagliflozine (insuffisance cardiaque, fraction d'éjection >40%)
Name of the manufacturer : Nora
Form : Co.
Dosage : 5 mg, 10 mg

Indication :

INESSS' Recommendation
Inscription - Sous conditions

Minister's decisions
Inscrire sur les listes des médicaments - Médicament
d'exception (2026-04-30)

Evaluation published on April 29, 2026

Subscribe to our newsletter now

Subscription